Showing results (61-70 of 201) with videos related to

Sort By:
Pageof 21
Expert Review of Hematology|September 1, 2020
Patient-reported symptom burden of chronic graft versus host disease: a systematic literature reviewMarcell Csanádi, Tamas Ágh, Szabolcs Farkas-Ráduly, et al.
Cancer|June 11, 2008
No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemiaDong Hwan Dennis Kim, Gizelle Popradi, Lakshmi Sriharsha, et al.
Psychology, Health & Medicine|June 24, 2008
Do allogeneic bone marrow transplant candidates match coping to controllability of pre-treatment stressors?Kenneth Mah, Mireille Khoraych, Jeffrey H Lipton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 17, 2009
Peripheral blood eosinophilia has a favorable prognostic impact on transplant outcomes after allogeneic peripheral blood stem cell transplantationDong Hwan Kim, Gizelle Popradi, Wei Xu, et al.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.
Hematology/Oncology and Stem Cell Therapy|March 8, 2021
Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource useIvan Pasic, Wael Alanazi, George Dranitsaris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significanceDeborah Siegal, Anne Keller, Wei Xu, et al.
Transfusion|April 5, 2003
RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survivalAnargyros Xenocostas, Angelina Yee, Cindy J Wong, et al.
Clinical Chemistry and Laboratory Medicine|January 19, 2023
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantationIvan Pasic, Annie H Ren, Ram Vasudevan Nampoothiri, et al.
Clinical Transplantation|December 6, 2013
Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host diseaseNaheed Alam, Eshetu G Atenafu, Garwin Tse, et al.
Pageof 21